|
Eric Donsky was appointed to the position of C.E.O. of OccuLogix in October 2008 and subsequently elected to the Board of Directors in September 2008.He has 15 years experience in the development of early-stage biotechnology and life science companies, as a founder and senior manager. Mr. Donsky has been the Chairman and Chief Executive Officer of OcuSense since January 2003. Mr. Donsky is also a principal of Melecular Biosciences, a life science incubator and consulting practice. Previously, he was the founding Chief Executive Officer of Zolaris BioSciences, Inc., an early-stage biotechnology company focused on the discovery and development of thereapeutics for the treatment of rheumatoid arthritis, multiple sclerosis and infectious disease. Prior to his tenure at Zolaris BioSciences, Inc., Mr. Donsky was the founding Chief Executive Officer of Applied CarboChemicals, Inc. (ACC), a biotechnology company focused on the commercial development of novel fermentation processes capable of manufacturing unique compounds that have application in the food, chemical and pharmaceutical industries. ACC currently has manufacturing operations and several products on the market. Mr. Donsky graduated from Boston University in 1987 with a B.Sc. in Business Administration. | 